logo
FDA Says It Might Change Infant Formula Requirements

FDA Says It Might Change Infant Formula Requirements

Epoch Times15-05-2025

The Food and Drug Administration (FDA) may change its nutrient requirements for infant formula, including floating the possibility of adding new mandated nutrients, the agency said on May 13.
The agency started a review of the nutrients that are currently in formula, in what regulators described as the first comprehensive review since 1998.
Through a
People have until the end of Sept. 11 to respond.
'You can't Make America Healthy Again if we don't fix what nourishes our youngest and most vulnerable Americans,' Health Secretary Robert F. Kennedy Jr.
Dr. Marty Makary, the FDA's commissioner, added: 'Protecting our most vulnerable is not just a moral duty—it is our responsibility. For many children, infant formula is their only source of nutrition. That's why it's absolutely crucial to continually assess the nutrition standards and incorporate gold standard science to ensure we are providing the safest, most effective nutrition possible.'
Related Stories
4/28/2025
3/19/2025
The Federal Food, Drug, and Cosmetic Act
The law also says that the nutrients shall be reviewed every four years by the health secretary 'as appropriate.' During such a review, 'the Secretary shall consider any new scientific data or information related to infant formula nutrients, including international infant formula standards,' the law states. 'The Secretary may revise the list of nutrients and the required level for any nutrient required by the table.'
Researchers have
The FDA's review is part of what officials are calling 'Operation Stork Speed,' an effort
Abbott Nutrition and Reckitt Benckiser-Mead Johnson produce just under 80 percent of the infant formula in the United States as of 2019, according to Euromonitor Passport data. The companies did not respond to requests for comment by publication time.
Perrigo, another major manufacturer, referred an inquiry to the Infant Nutrition Council of America (INCA).
'INCA members use safe, high-quality ingredients that are scientifically proven to provide the nutrients needed to support healthy infant growth and development—and industry stays dedicated to following the latest developments in health science and clinical research to support healthy infant growth and development,' a spokesperson for the council told The Epoch Times in an email.
'INCA members remain committed to working with HHS and the FDA on Operation Stork Speed to ensure domestic infant formula products continue to meet the highest standards for nutrition and safety, and today infant formula products undergo extensive research, stringent testing, and strict regulatory approval prior to going to market.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Health New England to replace Humira coverage with lower-cost biosimilars
Health New England to replace Humira coverage with lower-cost biosimilars

Yahoo

time2 hours ago

  • Yahoo

Health New England to replace Humira coverage with lower-cost biosimilars

SPRINGFIELD, Mass. (WWLP) – Health New England announced Monday that it will shift coverage of the biologic drug Humira to more affordable FDA-approved biosimilars starting next month for members of its commercial health plans. Markey playing defense against GOP clean energy plans Effective July 1, the not-for-profit health insurer will cover Amjevita by Nuvaila and Hadlima instead of Humira, as part of a broader effort to manage rising health care costs while maintaining access to effective treatments. Humira is used to treat several chronic inflammatory conditions, including rheumatoid arthritis, Crohn's disease, and plaque psoriasis. 'Biologic medications like Humira are complex treatments that carry significant cost. Its biosimilars provide a meaningful opportunity to enhance affordability for the health care ecosystem while members continue to get the full benefits of the medication,' said Gary Tereso, PharmD, Director of Pharmacy Services at Health New England. Biologic drugs are made from living organisms and are typically more expensive than other medications. Biosimilars are developed to be nearly identical in safety, potency, and efficacy to the original biologic, but at a significantly lower cost. The shift in coverage is intended to make treatment more accessible and financially sustainable for members and employer groups alike. Health New England is directly reaching out to members who are currently prescribed Humira, along with their health care providers and pharmacies, to assist with the transition. The company said it will continue monitoring the biosimilar marketplace to ensure members receive both high-quality care and cost-effective treatment options. WWLP-22News, an NBC affiliate, began broadcasting in March 1953 to provide local news, network, syndicated, and local programming to western Massachusetts. Watch the 22News Digital Edition weekdays at 4 p.m. on Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

MemoDefend Announces Official Website Update Featuring Natural Daily Supplement for Cognitive Support
MemoDefend Announces Official Website Update Featuring Natural Daily Supplement for Cognitive Support

Yahoo

time2 hours ago

  • Yahoo

MemoDefend Announces Official Website Update Featuring Natural Daily Supplement for Cognitive Support

Natural Brain Health Formula Now Available Online to Support Memory, Focus, and Cognitive Function in Adults Lakeland, June 09, 2025 (GLOBE NEWSWIRE) -- MemoDefend, a Florida-based wellness brand, has updated its official website to provide consumers with new information about its daily supplement formulated to support cognitive clarity and brain function in adults. Now available nationwide, the natural memory support formula is designed for individuals seeking a consistent, easy-to-integrate wellness solution. According to the official product website ( MemoDefend is intended to work in harmony with the body's internal processes to support healthy memory retention, mental sharpness, and overall cognitive performance. The brand highlights its approach as one that simplifies brain wellness without requiring restrictive regimens or complicated routines. 'We developed MemoDefend to help adults support brain health naturally—without disrupting their lifestyle,' said a company spokesperson. 'This product reflects our focus on purity, simplicity, and long-term wellness.' The company states that MemoDefend is produced in facilities that follow strict quality control practices. Its formulation features a selection of ingredients that align with adult wellness priorities such as cognitive support, mental clarity, and healthy aging. As noted on the website, MemoDefend includes a satisfaction guarantee for new customers. Those interested in learning more about its intended use or placing an order can find full details, customer support access, and purchasing options directly at the official website. About MemoDefend MemoDefend is a Lakeland, Florida-based wellness brand committed to delivering natural, easy-to-use supplements that support everyday health routines. Focused on transparency and simplicity, the company develops formulas to help adults feel more confident in their wellness journey—one daily step at a time. Product and Contact Information Brand: MemoDefendWebsite: support@ +1 (888) 535-1590Mailing Address: P.O. Box 90129, Lakeland, FL 33804, United States Disclaimer This release is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. The statements made about this product have not been evaluated by the Food and Drug Administration. Individual results may vary. Consumers should consult a qualified healthcare provider before beginning any new dietary supplement. CONTACT: Email: support@ Phone: +1 (888) 535-1590Sign in to access your portfolio

RFK Jr. reconstituting vaccine advisory committee, retiring 17 current members
RFK Jr. reconstituting vaccine advisory committee, retiring 17 current members

Business Insider

time3 hours ago

  • Business Insider

RFK Jr. reconstituting vaccine advisory committee, retiring 17 current members

In an opinion article published by The Wall Street Journal, Robert F. Kennedy Jr. stated: 'Vaccines have become a divisive issue in American politics, but there is one thing all parties can agree on: The U.S. faces a crisis of public trust. Whether toward health agencies, pharmaceutical companies or vaccines themselves, public confidence is waning… That is why, under my direction, the U.S. Department of Health and Human Services is putting the restoration of public trust above any pro- or antivaccine agenda… Today, we are taking a bold step in restoring public trust by totally reconstituting the Advisory Committee for Immunization Practices (ACIP). We are retiring the 17 current members of the committee, some of whom were last-minute appointees of the Biden administration. Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028… A clean sweep is needed to re-establish public confidence in vaccine science.' Confident Investing Starts Here:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store